Managed by Roubaix Capital, Llc • Latest filing Q2 2023
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| 5 | C CRS — | $6.5M | 96.1K | 0.00% | — |
| 6 | S SHC — | $6.1M | 408.4K | 0.00% | — |
| 7 | F | $6M | 215.1K | 0.00% | — |
| 8 | N NSSC — | $5.8M | 154.0K | 0.00% | — |
| 9 | P PKE — | $5.7M | 413.5K | 0.00% | — |
| 10 | A ATEX — | $5.2M | 163.5K | 0.00% | — |
| 11 | A ATEX — | $5.1M | 163.4K | 0.00% | — |
| 12 | G GENI — | $5M | 936.7K | 0.00% | — |
| 13 | C CRS — | $4.9M | 87.8K | 0.00% | — |
| 14 | P PKE — | $4.8M | 359.3K | 0.00% | — |
| 15 | A ASLE — | $4.8M | 278.9K | 0.00% | — |
| 16 | A ASLE — | $4.7M | 316.3K | 0.00% | — |
| 17 | N NPO — | $4.7M | 34.8K | 0.00% | — |
| 18 | M | $4.6M | 42.7K | 0.00% | — |
| 19 | V | $4.6M | 91.4K | 0.00% | — |
| 20 | ? N/A — | $4.6M | 132.3K | 0.00% | — |